Amid widespread speculations on the ethicality of applying genome-editing tools on humans, America’s National Academy of Sciences recently released a 216-page report, in which the influential body recommended the use of the controversial technology for preventing the birth of children with serious diseases.
The 22-member panel of eminent scientists and experts backed the heritable germline genome editing trials with a string of moral and technical caveats, notes MIT Technology Review. The panel opined that the technology should be used only when it is entirely safe and predictable and unambiguously differentiates between preventing disease and “enhancements.”
While a section of the scientist community welcomes the endorsement by the esteemed panel, many frown upon the very idea, which they believe paves the way a future where “designer babies” would be produced by altering the D.N.A. of human eggs, sperm, or early embryos.